3978 Federal Register / Vol. 73, No.
15 / Wednesday, January 23, 2008 / Notices
Dated: January 10, 2008.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–1016 Filed 1–22–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–08–06AP]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an e-
mail to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–6974. Written
Type of
respondent
All participants ....................................
Qualified participants ..........................
Dated: January 10, 2008.
Maryam Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E8–1017 Filed 1–22–08; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Center for Scientific
Review Special Emphasis Panel,
ebenthall on PROD1PC69 with NOTICES
February 13, 2008, 1 p.m. to February
13, 2008, 4:30 p.m., National Institutes
of Health, 6701 Rockledge Drive,
Bethesda, MD, 20892 which was
published in the Federal Register on
January 9, 2008, 73 FR 1634–1637.
VerDate Aug<31>2005 15:17 Jan 22, 2008 Jkt 214001
comments should be received within 30
days of this notice.
Proposed Project
Aerosol Generation by Cough—
NEW—The National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The National Institute for
Occupational Safety and Health
(NIOSH) is authorized to conduct
research to advance the health and
safety of workers under Section 20(a)(1)
of the 1970 Occupational Safety and
Health Act.
Many respiratory diseases are spread
when healthy people come into contact
with infectious fluids from sick
individuals. The most common mode of
transmission is direct contact with
infected persons, or contact with items
or people they have touched. In
addition, however, some respiratory
illnesses can also spread via infectious
aerosols that are generated by coughing
and sneezing. Riley et al. established
that tuberculosis is spread by inhalation
of respirable particles generated by
infected individuals. British studies of
ESTIMATED ANNUALIZED BURDEN HOURS
Form
Pre-test questionnaire ......................................................
Health questionnaire ........................................................
Consent form ....................................................................
The meeting will be held February 14,
2008. The meeting time and location
remains the same. The meeting is closed
to the public.
Dated: January 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–219 Filed 1–22–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meetings.
PO 00000 Frm 00058 Fmt 4703 Sfmt 4703
classrooms and offices found aerosols
containing viable salivary streptococci
and other oral bacteria that were
thought to be created during speaking,
coughing, and sneezing. Severe acute
respiratory syndrome (SARS) and avian
influenza are known to spread through
infectious aerosols, and this may
include cough-generated aerosols as
well.
The airborne transmission of disease
is of great concern to the public health
community because of the increasing
prevalence of drug-resistant strains of
tuberculosis, the epidemic potential of
newly-emerging diseases like avian
influenza, and the threat of bioterrorism
using agents such as bubonic plague.
The purpose of this project is to better
understand some of the factors involved
in the production of aerosols of airway
fluids by coughing. The project has two
specific aims: Measure the quantity and
size distribution of aerosol produced
during human coughs and determine
the effectiveness of surgical masks and
N95 respirators at filtering cough-
generated aerosols.
There is no cost to respondents other
than their time. The total estimated
annualized burden hours are 71.
Number of Average
Number of responses burden
respondents per per response
respondent (in hours)
147 1 5/60
140 1 5/60
140 1 20/60
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Biology of
Development and Aging Integrated Review
Group, Cellular Mechanisms in Aging and
Development Study Section.
Date: February 5–6, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Sir Francis Drake Hotel, Kimpton,
450 Powell Street, San Francisco, CA 94102.
Contact Person: James P. Harwood, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
E:\FR\FM\23JAN1.SGM 23JAN1
 Federal Register / Vol. 73, No. 15 / Wednesday, January 23, 2008 / Notices
Health, 6701 Rockledge Drive, Room 5168,
MSC 7840, Bethesda, MD 20892, 301–435–
1256, harwoodj@csr.nih.gov.
Name of Committee: Health of the
Population Integrated Review Group, Nursing
Science: Children and Families Study
Section.
Date: February 7, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda Marriott, 5151 Pooks Hill
Road, Bethesda, MD 20814.
Contact Person: Melinda Tinkle, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3141,
MSC 7770, Bethesda, MD 20892, 301–594–
6594, tinklem@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group, Intercellular
Interactions Study Section.
Date: February 7–8, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Washington, DC Hotel,
999 Ninth Street, NW., Washington, DC
20001.
Contact Person: David Balasundaram, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5189,
MSC 7840, Bethesda, MD 20892, 301–435–
1022, balasundaramd@csr.nih.gov.
Name of Committee: Health of the
Population Integrated Review Group, Health
Services Organization and Delivery Study
Section.
Date: February 7–8, 2008.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Reston, Reston Town
Center, 1800 Presidents Street, Reston, VA
20190.
Contact Person: Kathy Salaita, SCD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3172,
MSC 7770, Bethesda, MD 20892, 301–451–
8504, salaitak@csr.nih.gov.
Name of Committee: Health of the
Population Integrated Review Group,
Neurological, Aging and Musculoskeletal
Epidemiology Study Section.
Date: February 12–13, 2008.
Time: 8:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Harborplace Hotel, 202
East Pratt Street, Baltimore, MD 21202.
Contact Person: Heidi B. Friedman, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1012A,
MSC 7770, Bethesda, MD 20892, 301–435–
1721, hfriedman@csr.nih.gov.
Name of Committee: Genes, Genomes, and
ebenthall on PROD1PC69 with NOTICES
Genetics Integrated Review Group, Molecular
Gentics C Study Section.
Date: February 12–13, 2008.
Time: 8:30 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Aug<31>2005 15:17 Jan 22, 2008 Jkt 214001
Place: Lombardy Hotel, 2019 Pennsylvania
Avenue, NW., Washington, DC 20006.
Contact Person: Barbara Whitmarsh, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2206,
MSC 7890, Bethesda, MD 20892, 301–435–
4511, whitmarshb@csr.nih.gov.
Name of Committee: Immunology
Integrated Review Group, Cellular and
Molecular Immunology—B Study Section.
Date: February 13–14, 2008.
Time: 8 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marina del Rey Hotel, 13534 Bali
Way, Marina del Rey, CA 90292.
Contact Person: Betty Hayden, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4206,
MSC 7812, Bethesda, MD 20892, 301–435–
1223, haydenb@csr.nih.gov.
Name of Committee: Oncological Sciences
Integrated Review Group, Tumor Progression
and Metastasis Study Section.
Date: February 14–15, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Ritz Carlton Hotel, 1150 22nd Street,
NW., Washington, DC 20037.
Contact Person: Manzoor Zarger, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6208,
MSC 7804, Bethesda, MD 20892, (301) 435–
2477, zargerma@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Vectors.
Date: February 14–15, 2008.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Fouad A. El-Zaatari, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
MSC 7808, Bethesda, MD 20814–9692, (301)
435–1149, elzaataf@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Clinical
Molecular Imaging (Overflow).
Date: February 15, 2008.
Time: 3 p.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bahia Resort Hotel, 998 West
Mission Bay Drive, San Diego, CA 92109.
Contact Person: Eileen W. Bradley, DSC,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5100,
MSC 7854, Bethesda, MD 20892, (301) 435–
1179, bradleye@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Social
Science and Population Studies R03s, R15s,
and R21s.
Date: February 15, 2008.
Time: 8 a.m. to 5 p.m.
PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 E:\FR\FM\23JAN1.SGM
3979
Agenda: To review and evaluate grant
applications.
Place: Marina del Rey Hotel, 13534 Bali
Way, Marina del Rey, CA 90292.
Contact Person: Valerie Durrant, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3148,
MSC 7770, Bethesda, MD 20892, (301) 435–
3554, durrantv@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Topics in
Aging and Development.
Date: February 15, 2008.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Francois Boller, MD, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3206,
MSC 7848, Bethesda, MD 20892, (301) 435–
1019, bollerf@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Member
Conflicts: Child Development and
Developmental Disorder.
Date: February 19–20, 2008.
Time: 8 a.m. to 9 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Estina E. Thompson, MPH,
PhD, Scientific Review Administrator, Center
for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3178,
MSC 7848, Bethesda, MD 20892, 301–496–
5749, thompson@mail.nih.gov.
Name of Committee: Renal and Urological
Studies Integrated Review Group, Urologic
and Kidney Development and Genitourinary
Diseases Study Section.
Date: February 21, 2008.
Time: 8 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Lombardy, 2019 Pennsylvania
Avenue, Washington, DC 20006.
Contact Person: Ryan G. Morris, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4205,
MSC 7814, Bethesda, MD 20892, 301–435–
1501, morrisr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Clinical
Hematology.
Date: February 22, 2008.
Time: 8 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Holiday Inn Georgetown, 2101
Wisconsin Avenue, NW., Washington, DC
20007.
Contact Person: Bukhtiar H. Shah, DVM,
PhD, Scientific Review Offier, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4213,
MSC 7802, Bethesda, MD 20892, (301) 435–
1233, shahb@csr.nih.gov.
23JAN1
 3980 Federal Register / Vol. 73, No. 15 / Wednesday, January 23, 2008 / Notices
Name of Committee: Center for Scientific
Review Special Emphasis Panel, Chronic
Fatigue and Fibromyalgia Syndromes,
Temporomandibular Disorders.
Date: February 22, 2008.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call).
Contact Person: J. Terrell Hoffeld, DDS,
PhD, Dental Officer, USPHS, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4116,
MSC 7816, Bethesda, MD 20892, 301–435–
1781, th88q@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, DNA Repair
and Carcinogenesis.
Date: February 26, 2006.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Denise R. Shaw, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6158,
MSC 7804, Bethesda, MD 20892, 301–435–
0198, shawkath@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphsis Panel, Pilot and
Feasibility Clinical Studies in Digestive
Diseases and Nutrition.
Date: February 27, 2008.
Time: 1 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call)
Contact Person: Peter J. Perrin, PhD,
Scientific Review Administrator, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2180,
MSC 7818, Bethesda, MD 20892, (301) 435–
0682, perrinp@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–224 Filed 1–22–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
ebenthall on PROD1PC69 with NOTICES
Center for Scientific Review; Amended
Notice of Meeting
Notice is hereby given of a change in
the meeting of the Macromolecular
VerDate Aug<31>2005 18:31 Jan 22, 2008 Jkt 214001
Structure and Function D Study
Section, February 7, 2008, 8 a.m. to
February 8, 2008, 6 p.m., Hilton Long
Beach & Executive Meeting Center, 701
West Ocean Boulevard, Long Beach, CA,
90831 which was published in the
Federal Register on January 9, 2008, 73
FR 1637–1639.
The meeting will be held one day
only February 7, 2008, from 8 a.m. to 6
p.m. The meeting location remains the
same. The meeting is closed to the
public.
Dated: January 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–225 Filed 1–22–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendex 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals assocaited with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Clinical Investigator Awards (K08s).
Date: January 29, 2008.
Time: 12 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: David A. Wilson, PhD,
Scientific Review Administrator, Review
Branch/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7204, Bethesda, MD 20892–7924, 301–435–
0299, wilsonda2@nhlbi.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
PO 00000 Frm 00060 Fmt 4703 Sfmt 4703 E:\FR\FM\23JAN1.SGM
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–220 Filed 1–22–08: 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute on
Drug Abuse Special Emphasis Panel,
February 1, 2008, 1 p.m. to February 1,
2008, 5 p.m., National Institutes of
Health, 6101 Executive Boulevard,
Rockville, MD 20852 which was
published in the Federal Register on
January 9, 2008, Volume 73, Number 6.
The date of the meeting was changed
to February 22, 2008. The meeting is
closed to the public.
Dated: January 15, 2008.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 08–221 Filed 1–22–08; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Drug Abuse Special Emphasis Panel, NIDA-
L New Investigator R01 SEP.
Date: February 21, 2008.
Time: 12:30 p.m. to 3 p.m.
23JAN1